Instrument Inactif

Communiqués Panacos Pharmaceuticals, Inc. Other OTC

Actions

PANC

US69811Q1067

Recherche biotechnologique et médicale

Communiqués

30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference	BU
30/11/-1	Panacos Pharma : Panacos Reports Second Quarter 2007 Financial Results	BU
30/11/-1	Panacos Pharma : Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference	BU
30/11/-1	Panacos Pharma : Panacos to Report Second Quarter Results for 2007	BU
30/11/-1	Panacos Pharma : Panacos Secures $20 Million Debt Financing	BU
30/11/-1	Panacos Pharma : Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study	BU
30/11/-1	Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	BU
30/11/-1	Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference	BU
30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Biotech Confab	BU
30/11/-1	Panacos Pharma : Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat	BU
30/11/-1	Panacos Pharma : Panacos to Present at Bank of America Health Care Conference	BU
30/11/-1	Panacos Pharma : Panacos Reports First Quarter 2007 Financial Results	BU
30/11/-1	Panacos Pharma : Panacos to Present at Deutsche Bank Health Care Conference	BU
30/11/-1	Panacos Pharma : Panacos to Report First Quarter Results for 2007	BU
30/11/-1	Panacos Pharma : Panacos Announces New Board Member	BU
30/11/-1	Panacos Pharma : Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference	BU
30/11/-1	Panacos Pharma : Panacos Completes Pre-clinical Studies Indicating Bevirimat Is Non-Teratogenic	BU
30/11/-1	Panacos Pharma : Panacos Presents Progress on HIV Fusion Inhibitor Program at International AIDS Conference	BU
30/11/-1	Panacos Pharma : Panacos to Present Data at 46th Annual ICAAC	BU
30/11/-1	Panacos Pharma : Panacos to Present at UBS Global Life Sciences Conference	BU
30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference	BU
30/11/-1	Panacos Pharma : Panacos to Report Third Quarter 2006 Results	BU
30/11/-1	Panacos Pharma : Panacos to Present at BIO Investor Forum	BU
30/11/-1	Panacos Pharma : Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy	BU
30/11/-1	Panacos Pharma : Panacos to Present at Citigroup Small & Mid-Cap Conference	BU